These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6155686)

  • 1. Intestinal concentrations of pancreatic enzymes following pancreatic replacement therapy.
    Ihse I; Lilja P; Lundquist I
    Scand J Gastroenterol; 1980; 15(2):137-44. PubMed ID: 6155686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pancreatic enzymes--substitution preparations].
    Berndt W
    Z Allgemeinmed; 1972 Dec; 48(35):1641-4. PubMed ID: 4649287
    [No Abstract]   [Full Text] [Related]  

  • 3. Fate of pancreatic enzymes in the human intestinal lumen in health and pancreatic insufficiency.
    Layer P; Gröger G
    Digestion; 1993; 54 Suppl 2():10-4. PubMed ID: 7693530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of enzyme substitution in patients with pancreatic insufficiency.
    Worning H
    Scand J Gastroenterol; 1980; 15(5):529-33. PubMed ID: 6160608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal activities of trypsin, lipase, and phospholipase after a test meal. An evaluation of 474 examinations.
    Ihse I; Arnesjö B; Kugelberg C; Lilja P
    Scand J Gastroenterol; 1977; 12(6):663-8. PubMed ID: 929105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the fluorescein dilaurate test suitable for monitoring the effectiveness of pancreatic enzyme replacement therapy?
    Burrell LM; Boyd EJ; Wormsley KG
    Scand J Clin Lab Invest; 1991 Dec; 51(8):675-80. PubMed ID: 1725463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency.
    Pap A; Varró V
    Hepatogastroenterology; 1984 Feb; 31(1):47-50. PubMed ID: 6199274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency.
    Regan PT; Malagelada JR; DiMagno EP; Glanzman SL; Go VL
    N Engl J Med; 1977 Oct; 297(16):854-8. PubMed ID: 20572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of lipolytic pancreatic enzymes in an adult man.
    Arnesjö B; Ihse I; Odeberg H; Stahl E
    Digestion; 1974; 11(1-2):147-51. PubMed ID: 4452422
    [No Abstract]   [Full Text] [Related]  

  • 11. Pancreatic enzymic activities of commercial pancreatic enzyme preparations incubated in human small intestinal juice.
    Ihse I; Lilja P
    Digestion; 1979; 19(1):48-51. PubMed ID: 456768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative trial of Nutrizym in chronic pancreatic insufficiency.
    Knill-Jones RP; Pearce H; Batten J; Williams R
    Br Med J; 1970 Oct; 4(5726):21-4. PubMed ID: 4919118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of isoproteic and lipid rich diets on lipase, phospholipase A2, cholesterolesterase, trypsin and amylase activities in rat pancreatic juice and pancreas (author's transl)].
    Prost J; Gillet M; Belleville J
    J Physiol (Paris); 1978; 74(8):743-54. PubMed ID: 753926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity of lipase and trypsin in the duodenal juice].
    Tosić S; Potkonjak D; Kusić M
    Srp Arh Celok Lek; 1972 Sep; 100(9):1033-9. PubMed ID: 4663829
    [No Abstract]   [Full Text] [Related]  

  • 16. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules.
    DiMagno EP; Malagelada JR; Go VL; Moertel CG
    N Engl J Med; 1977 Jun; 296(23):1318-22. PubMed ID: 16213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New methods for assessment of enzyme activity: do they help to optimize enzyme treatment?
    Adler G; Mundlos S; Kühnelt P; Dreyer E
    Digestion; 1993; 54 Suppl 2():3-9. PubMed ID: 7693531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Substitution therapy with pancreatic enzymes].
    Tillander H
    Lakartidningen; 1971 Feb; 68(8):825-32. PubMed ID: 5546731
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in pancreatic and intestinal enzyme activities following chenodeoxycholic acid feeding.
    O'Donnell MD; Fitzgerald O; McGeeney KF
    Scand J Gastroenterol; 1977; 12(6):683-7. PubMed ID: 929107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Löhr JM; Hummel FM; Pirilis KT; Steinkamp G; Körner A; Henniges F
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1024-31. PubMed ID: 19352190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.